Ivantis Hydrus Microstent Beats Glaukos iStent In Glaucoma Study

In the randomized COMPARE trial, eyes treated with Ivantis' Hydrus Microstent were about twice as likely to not need medication than eyes treated with two Glaukos iStent trabecular micro-bypass stents one year after implant  The one-year results of the trial have been accepted for publication in Opthalmology. 

Ivantis Hydrus Microstent
Hydrus Microstent • Source: Ivantis Inc.

[Editor's note:Complete historical information on important medical device trial announcements is available from Informa’s Meddevicetracker. For an archive of previous Medtech Insight articles on medtech clinical trials, visit the Tracking Trials page.]

Results from the COMPARE randomized trial show open-angle glaucoma patients treated with Ivantis Inc.'s Hydrus Microstent are less likely to need eye medication a year after receiving the...

More from Clinical Trials

More from R&D